Xconomy

SEPTEMBER 27, 2016

San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). Lilly Asia Ventures, Osage University Partners, and Vivo Capital joined in the deal, according to a statement from Avalon. 9/27/16, 2:09 p.m. Bregua Corp.,

Avalon 40

Avalon Funding Startup San Diego 40

Xconomy

AUGUST 17, 2016

and San Diego’s Avalon Ventures. Inbio Ventures, a venture capital management company, represented Pharmstandard in the deal. Avalon Ventures founded Avelas, and has housed the startup with other Avalon biotech startups at its COI Pharmaceuticals R&D facility in San Diego. Carmine Stengone.

Avalon 40

Avalon San Diego Study Invest 40

Xconomy

JULY 20, 2016

Then came COI Pharmaceuticals , the shared “community of innovation” for startup biotechs established by San Diego’s Avalon Ventures as part of its partnership with GlaxoSmithKline. It’s a little like what Avalon is doing. We are taking capital as needed, not sooner.”. But it’s structured differently.

San Diego 40

San Diego Avalon Outsource Development Newsletter 40